J. Thistlethwaite to Time Factors
This is a "connection" page, showing publications J. Thistlethwaite has written about Time Factors.
Connection Strength
0.571
-
Racial disparities in reaching the renal transplant waitlist: is geography as important as race? Clin Transplant. 2015 Jun; 29(6):531-8.
Score: 0.070
-
A review of longitudinal community and hospital placements in medical education: BEME Guide No. 26. Med Teach. 2013 Aug; 35(8):e1340-64.
Score: 0.061
-
Potential inefficiency of a proposed efficiency model for kidney allocation. Am J Kidney Dis. 2008 Apr; 51(4):545-8.
Score: 0.043
-
Absence of host B7 expression is sufficient for long-term murine vascularized heart allograft survival. Transplantation. 2000 Mar 15; 69(5):904-9.
Score: 0.024
-
Humanized, nonmitogenic OKT3 antibody, huOKT3 gamma(Ala-Ala): initial clinical experience. Transplant Proc. 1998 Jun; 30(4):1369-70.
Score: 0.022
-
An analysis of hepatic retransplantation in children. Transplantation. 1998 May 15; 65(9):1172-8.
Score: 0.022
-
Retransplantation for failed hepatic allografts in children. Transplant Proc. 1997 Feb-Mar; 29(1-2):442-3.
Score: 0.020
-
Impact of a liberalized donor acceptance policy on liver transplantation. Transplant Proc. 1997 Feb-Mar; 29(1-2):484.
Score: 0.020
-
Long-term outcome of kidney-pancreas transplant recipients with good graft function at one year. Transplantation. 1996 Aug 27; 62(4):451-6.
Score: 0.019
-
Outcome of monoclonal antibody induction and anti-rejection therapy in pancreas transplantation. Transplant Proc. 1996 Aug; 28(4):2136-7.
Score: 0.019
-
FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation. Clin Transplant. 1996 Aug; 10(4):323-32.
Score: 0.019
-
Tacrolimus for primary treatment of steroid-resistant hepatic allograft rejection. Transplantation. 1996 May 15; 61(9):1365-9.
Score: 0.019
-
Late complications in kidney-pancreas transplant recipients. Transplant Proc. 1995 Dec; 27(6):3118.
Score: 0.018
-
Age and equity in liver transplantation: An organ allocation model. Liver Transpl. 2015 Oct; 21(10):1241-9.
Score: 0.018
-
Intrathymic xenogeneic pancreatic islet transplantation--induction of donor-specific unresponsiveness by MHC class II peptides. Transplant Proc. 1995 Feb; 27(1):176-7.
Score: 0.017
-
Prolongation of skin xenograft survival with concomitant donor bone marrow transplantation. Transplant Proc. 1994 Jun; 26(3):1201-2.
Score: 0.016
-
Low-dose anti-CD3 therapy provides long-term graft survival in a Lewis rat to C57BL/6 xeno-islet transplantation model. Transplant Proc. 1994 Apr; 26(2):771-3.
Score: 0.016
-
Insulin secretory profiles and C-peptide clearance kinetics at 6 months and 2 years after kidney-pancreas transplantation. Diabetes. 1992 Oct; 41(10):1346-54.
Score: 0.015
-
Changing attitudes toward influenza vaccination in U.S. Kidney transplant programs over the past decade. Clin J Am Soc Nephrol. 2010 Sep; 5(9):1637-41.
Score: 0.012
-
Does depletion of donor dendritic cells in an organ allograft lead to prolongation of graft survival on transplantation? Transplant Proc. 1989 Feb; 21(1 Pt 1):482-3.
Score: 0.011
-
Complications and monitoring of OKT3 therapy. Am J Kidney Dis. 1988 Feb; 11(2):112-9.
Score: 0.011
-
Use of a brief steroid trial before initiating OKT3 therapy for renal allograft rejection. Am J Kidney Dis. 1988 Feb; 11(2):94-8.
Score: 0.011
-
Elective conversion from cyclosporine to azathioprine in recipients with stable renal function 6 months after kidney transplantation. Hum Immunol. 1985 Nov; 14(3):314-23.
Score: 0.009
-
Different mechanisms of cardiac allograft rejection in wildtype and CD28-deficient mice. Am J Transplant. 2001 May; 1(1):38-46.
Score: 0.007
-
Role of STAT6 signaling in the induction and long-term maintenance of tolerance mediated by CTLA4-Ig. Transplant Proc. 2001 Feb-Mar; 33(1-2):214-6.
Score: 0.006
-
Evaluation of pre- and posttransplant donor-specific transfusion/cyclosporine A in non-HLA identical living donor kidney transplant recipients. Cooperative Clinical Trials in Transplantation Research Group. Transplantation. 1999 Oct 27; 68(8):1117-24.
Score: 0.006
-
Differential effect of an anti-CD8 monoclonal antibody on rejection of murine intestine and cardiac allografts. Transplant Proc. 1999 Feb-Mar; 31(1-2):1239-41.
Score: 0.006
-
The role of CD8 and CD4 T cells in intestinal allograft rejection: a comparison of monoclonal antibody-treated and knockout mice. Transplantation. 1999 Jan 15; 67(1):131-7.
Score: 0.006
-
Tacrolimus therapy for refractory renal allograft rejection: experience with steroid withdrawal. Transplant Proc. 1997 Feb-Mar; 29(1-2):307.
Score: 0.005
-
Biliary complications in living donor liver transplantation. Transplant Proc. 1997 Feb-Mar; 29(1-2):419-20.
Score: 0.005
-
Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506. Transplant Proc. 1996 Apr; 28(2):998-9.
Score: 0.005
-
OKT3 prophylaxis in renal grafts with prolonged cold ischemia times: association with improvement in long-term survival. Kidney Int. 1996 Mar; 49(3):768-72.
Score: 0.005
-
A randomized clinical trial of induction therapy with OKT3 in kidney transplantation. Transplantation. 1993 Jan; 55(1):44-50.
Score: 0.004
-
Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. Science. 1992 Aug 07; 257(5071):789-92.
Score: 0.004
-
Bacterial infection as a complication of liver transplantation: epidemiology and risk factors. Rev Infect Dis. 1991 May-Jun; 13(3):387-96.
Score: 0.003